Targeting the type 1 insulin-like growth factor receptor as anti-cancer treatment.
about
Markers of resistance to anti-EGFR therapy in colorectal cancerInsulin-like growth factor and epidermal growth factor signaling in breast cancer cell growth: focus on endocrine resistant diseaseInsulin-like growth factor system in cancer: novel targeted therapiesThe insulin-like growth factor-I receptor (IGF-IR) in breast cancer: biology and treatment strategies.Activation of the insulin-like growth factor-1 receptor induces resistance to epidermal growth factor receptor antagonism in head and neck squamous carcinoma cells.Inhibition of IGF-1 signalling enhances the apoptotic effect of AS602868, an IKK2 inhibitor, in multiple myeloma cell lines.Targeting of bone-derived insulin-like growth factor-II by a human neutralizing antibody suppresses the growth of prostate cancer cells in a human bone environment.Phenothiourea sensitizes zebrafish cranial neural crest and extraocular muscle development to changes in retinoic acid and IGF signalingEvaluation of a novel hexavalent humanized anti-IGF-1R antibody and its bivalent parental IgG in diverse cancer cell linesCase series of dermatologic events associated with the insulin-like growth factor receptor 1 inhibitor cixutumumab.Doxorubicin plus the IGF-1R antibody cixutumumab in soft tissue sarcoma: a phase I study using the TITE-CRM model.Antiepidermal growth factor receptor therapy in squamous cell carcinoma of the head and neck.Anti-CD19 and anti-CD22 monoclonal antibodies increase the effectiveness of chemotherapy in Pre-B acute lymphoblastic leukemia cell lines.Cixutumumab-associated pancolitis in a patient with prostate cancer.miR-223 enhances the sensitivity of non-small cell lung cancer cells to erlotinib by targeting the insulin-like growth factor-1 receptor.Bypassing cellular EGF receptor dependence through epithelial-to-mesenchymal-like transitionsIncreased insulin-like growth factor 1 receptor (IGF1R) expression in small cell lung cancer and the effect of inhibition of IGF1R expression by RNAi on growth of human small cell lung cancer NCI-H446 cell.Increased expression of insulin-like growth factor-1 receptor is correlated with tumor metastasis and prognosis in patients with osteosarcoma.Insulin-like growth factor-1 receptor and ErbB kinase inhibitor combinations block proliferation and induce apoptosis through cyclin D1 reduction and Bax activation.
P2860
Q24598640-BDF09A3D-EB3E-42A9-AC6C-DEC4638A5DBFQ26800001-62E12366-C304-4BD8-A19A-A1160DAEB028Q28081603-E15D11DB-677E-45F0-8072-1723FCFDA10DQ30244095-B7444B8F-2BAC-4095-9C19-334B6F9545ABQ30424348-D5315BD9-478B-44C4-9B6A-46BAF0EDC391Q31028788-6C6F5651-34F0-428D-8953-2CE55F073C12Q33575740-0680AA12-700D-4AE4-BBEC-E78F7CB269CEQ34008775-2130B934-D63A-43C3-9CEE-F4968FE738FCQ34406479-A689AEFA-105B-41F8-9D9C-FCB5CA3BDC6BQ35112345-83556507-5055-4DE5-8536-A0011B57EE05Q35775234-8EB7325E-D3DE-4477-9EEF-4528C36EC8A4Q36072292-820BFAE5-76DA-431C-8CC8-EC3859C596DEQ36512143-7592651E-D3DD-4042-9A08-240944971964Q36628533-5A75C26D-8DE3-4E4B-B859-0ED383FD28C0Q36983803-8572D801-20EE-4F8C-98AB-26A7731C1B45Q37072581-1A94E3CB-8C61-4916-B33E-84041C26BCB3Q38830819-247889E9-CAFB-4904-A972-7AA4B212E084Q39484775-3C03A004-A5F3-4378-84B6-2B5664EB3142Q39971767-D7D55844-64CE-42BC-993E-07B3A2EBE1A2
P2860
Targeting the type 1 insulin-like growth factor receptor as anti-cancer treatment.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Targeting the type 1 insulin-like growth factor receptor as anti-cancer treatment.
@ast
Targeting the type 1 insulin-like growth factor receptor as anti-cancer treatment.
@en
type
label
Targeting the type 1 insulin-like growth factor receptor as anti-cancer treatment.
@ast
Targeting the type 1 insulin-like growth factor receptor as anti-cancer treatment.
@en
prefLabel
Targeting the type 1 insulin-like growth factor receptor as anti-cancer treatment.
@ast
Targeting the type 1 insulin-like growth factor receptor as anti-cancer treatment.
@en
P2093
P1433
P1476
Targeting the type 1 insulin-like growth factor receptor as anti-cancer treatment.
@en
P2093
Erin A Bohula
Martin P Playford
Valentine M Macaulay
P304
P356
10.1097/00001813-200310000-00001
P577
2003-10-01T00:00:00Z